Examples of 'tumor-associated' in a sentence
Meaning of "tumor-associated"
tumor-associated (verb) - Refers to something that is connected or related to a tumor. This term is commonly used in medical contexts when discussing factors or conditions associated with tumors.
How to use "tumor-associated" in a sentence
Basic
Advanced
tumor-associated
Numerous tumor-associated antigens are known in the art.
Target molecules also include tumor-associated antigens.
Other tumor-associated antigens are known in the art.
Cancer cells excessively express tumor-associated antigens.
Tumor-associated mutations can result in protein fusions.
Data mining is a known method of identifying tumor-associated genes.
When exposed to tumor-associated enzymes or acidic pH may be used.
Peptide vaccines for cancers expressing tumor-associated antigens.
Identification of tumor-associated antigens for diagnosis and therapy.
The cell proliferative condition may be a tumor-associated cancer.
Any tumor-associated pain usually subsides after tumor removal.
These abnormally expressed antigens are known as tumor-associated antigens.
Tumor-associated antigens are well known and described in the art.
In certain embodiments, the tumor-associated antigen is a proteinaceous tumor antigen.
Tumor-associated mutations can affect the effectiveness of cancer treatments.
See also
Loss of adipocyte specification and necrosis augment tumor-associated inflammation.
Preferably, a tumor-associated antigen is presented by a cancer cell in which it is expressed.
In some embodiments, the immunocytokine binds specifically to a tumor-associated antigen.
Preferably, a tumor-associated antigen is presented by a malignant cell in which it is expressed.
The plasmids are used as vectors that encode tumor-associated antigens.
The nature of tumor-associated antigens were unknown for a long time.
Cancer cells express aberrant molecules known as tumor-associated antigens.
A tumor-associated mutation or a cancer-associated mutation can be a somatic mutation.
A polyclonal or monoclonal antibody which is capable of binding to a tumor-associated antigen.
A number of tumor-associated antigens have been described for breast carcinomas.
In one embodiment the target protein is a cell surface tumor-associated antigen.
Lastly, a strong tumor-associated inflammatory response can be initiated by cancer therapy.
In a further aspect, the disclosure relates to an immunogenic fragment of a tumor-associated antigen.
The activity of a tumor-associated antigen can be any activity of a protein or a peptide.
Particularly preferred immunoglobulins are those that can recognize a tumor-associated antigen.
Antigens include tumor-associated antigens for the prevention or treatment of cancers.
This was done to make sure that the correct tumor-associated sequence was determined.
Tumor-associated antigens can be prepared by methods well known in the art.
Target molecules also include tumor-associated antigens, as described elsewhere herein.
In a particular embodiment, said antigenic material is a microbial or tumor-associated antigenic material.
The best-characterized human tumor-associated antigens are the oncofetal antigens.
Preferred antibodies comprise antibodies which bind selectively a tumor-associated antigen.
A large number of exemplary solid tumor-associated antigens are listed herein below.
In some embodiments, immunocytokines are provided that bind specifically to tumor-associated antigens.
Also a strong tumor-associated inflammatory response can be initiated by cancer therapy.
Pathological processes involving this action include tumor-associated cell growth.
Such indirectly tumor-associated antigens may also be targets of a vaccination approach.
Dna composition for eliciting an immune response against tumor-associated macrophages.
In this case, the tumor-associated antigen is then specifically expressed in these organs.
The problem of tumor heterogeneity is supposed to be reduced by targeting the tumor-associated vasculature.
However, it is also possible to use tumor-associated antigens from a tumor cell line.
Particularly preferred immunoglobulins are those immunoglobulins which can recognize a tumor-associated antigen.
Said antigen or peptide is a tumor-associated antigen or derived from the source of infection ; or.
In a further embodiment, the second composition further comprises the tumor-associated antigen.
Lastly, a strong tumor-associated inflammatory response can be initiated by cancer therapy.
